Product Information

ATOMOXETINE HCL 18 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3666 per EA under NDC 00093354356. Its NADAC has been published 483 times since Aug 23, 2017.

FDA first approved this application on May 30, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATOMOXETINE HCL 18 MG CAPSULE

Atomoxetine
$0.3666per EA

Strength

18 mg/1

NDC

00093354356

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ATOMOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079022

FDA Approved

5/30/2017

TE Code

AB

On Market Since

5/30/2017

Pharmacological Classes

Norepinephrine Reuptake Inhibitor
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for ATOMOXETINE HCL 18 MG CAPSULE has been published 483 times since Aug 23, 2017, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3666 per EA
All-time high$4.0610 (Sep 13, 2017)
All-time low$0.3666 (Nov 18, 2026)
52-week high$0.5340
52-week low$0.3666
Median price$1.0576
Average price$1.3907
Largest weekly change-33.1% (Sep 20, 2023)
Weeks tracked483
Tracking sinceAug 23, 2017

Price History

1W

-5.4%

1M

-4.0%

3M

-10.3%

6M

-24.1%

1Y

-24.6%

3Y

-46.0%

5Y

-70.7%

All

-91.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ATOMOXETINE HCL 18 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ATOMOXETINE HCL 18 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.3666 per EA (NDC 00093354356), effective Nov 18, 2026.

How has the price of ATOMOXETINE HCL 18 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ATOMOXETINE HCL 18 MG CAPSULE has declined 91.0%. It has been tracked across 483 weekly CMS publications since Aug 23, 2017.

What are the highest and lowest recorded NADAC prices for ATOMOXETINE HCL 18 MG CAPSULE?

Since Aug 23, 2017, the NADAC for ATOMOXETINE HCL 18 MG CAPSULE has ranged from a low of $0.3666 (Nov 18, 2026) to a high of $4.0610 (Sep 13, 2017), with a median of $1.0576 per EA.

Are there cheaper alternatives to ATOMOXETINE HCL 18 MG CAPSULE?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATOMOXETINE HCL 18 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures ATOMOXETINE HCL 18 MG CAPSULE?

ATOMOXETINE HCL 18 MG CAPSULE (NDC 00093354356) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.